Prestige Consumer Healthcare
289 hedge funds and large institutions have $2.91B invested in Prestige Consumer Healthcare in 2022 Q4 according to their latest regulatory filings, with 39 funds opening new positions, 102 increasing their positions, 116 reducing their positions, and 26 closing their positions.
200% more funds holding in top 10
Funds holding in top 10: 1 → 3 (+2)
50% more first-time investments, than exits
New positions opened: 39 | Existing positions closed: 26
17% more capital invested
Capital invested by funds: $2.49B → $2.91B (+$414M)
4% more funds holding
Funds holding: 279 → 289 (+10)
0.3% more ownership
Funds ownership: 100.59% → 100.88% (+0.3%)
12% less repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 116
69% less call options, than puts
Call options by funds: $244K | Put options by funds: $791K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$56.5M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
+$24.8M |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$6.69M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$6.37M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$5.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$26.7M |
| 2 |
Fisher Asset Management
Camas,
Washington
|
-$15.4M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$11.5M |
| 4 |
Jennison Associates
New York
|
-$10.1M |
| 5 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$8.88M |
PBH Hedge Fund Activity: Q4 2022 in Review
289 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q4 2022, worth a combined $2.91B — up 17% from $2.49B a quarter earlier.
Buyers outnumbered sellers: 39 funds opened new PBH positions and 26 closed out — a net gain of 13 holders — while 102 added to existing stakes and 116 trimmed.
The largest buyer was BlackRock, adding an estimated $56.5M. The largest seller was Royal Bank of Canada, cutting an estimated $26.7M.
- 289 institutional investors held Prestige Consumer Healthcare (PBH) as of Q4 2022, up from 279 in Q3 2022.
- Funds reported $2.91B of Prestige Consumer Healthcare stock for Q4 2022, up 17% quarter-over-quarter.
- 39 funds opened new Prestige Consumer Healthcare positions in Q4 2022 and 26 closed out, a net change of +13 holders.
- The largest Prestige Consumer Healthcare buyer in Q4 2022 was BlackRock, an estimated $56.5M added.
- The largest Prestige Consumer Healthcare seller in Q4 2022 was Royal Bank of Canada, an estimated $26.7M sold.
Based on aggregated 13F filings for Q4 2022.